BRAF and Miyoshi myopathy: Our literature review indicated that MM with pituitary metastasis demonstrates male predominance, a median onset age of 62 years, a frequent association with <i>BRAF</i> V600E mutation, and a median survival time of 12 months.<h4>Conclusion</h4>Diagnosing MM with pituitary metastasis requires integrating detailed clinical history, imaging features, pathological examination, and molecular testing.